DB-2304 not checked

DualityBio Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
Main trialPhase 1/2
“A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus”In the company’s words, NCT06625671 on ClinicalTrials.gov

Other drugs for Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

All 131 drugs for Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 30 Jun 2027 A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow DB-2304

Following is part of Solo: you see every change to DB-2304 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in